Gritstone bio, Inc. - stock earnings
GRTS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -30.8 million USD | 29000 USD |
| 2023Q3 | -38.4 million USD | 1.6 million USD |
| 2023Q2 | -35.3 million USD | 400000 USD |
| 2023Q1 | -34.0 million USD | 542000 USD |
| 2022Q4 | -30.7 million USD | 1.3 million USD |
| 2022Q3 | -30.1 million USD | 436000 USD |
| 2022Q2 | -29.2 million USD | 2.8 million USD |
| 2022Q1 | -28.8 million USD | 4.7 million USD |
| 2021Q4 | -29.8 million USD | 1.8 million USD |
| 2021Q3 | -28.1 million USD | 2.4 million USD |
| 2021Q2 | -25.1 million USD | 2.8 million USD |
| 2021Q1 | 7.9 million USD | 39.7 million USD |
| 2020Q4 | -27.2 million USD | 1.3 million USD |
| 2020Q3 | -26.1 million USD | 939000 USD |
| 2020Q2 | -25.9 million USD | 488000 USD |
| 2020Q1 | -26.2 million USD | 1.3 million USD |
| 2019Q4 | -27.7 million USD | 884000 USD |
| 2019Q3 | -27.5 million USD | 984000 USD |
| 2019Q2 | -21.2 million USD | 1.2 million USD |
| 2019Q1 | -18.0 million USD | 1.3 million USD |
| 2018Q4 | -17.3 million USD | 1.1 million USD |
| 2018Q3 | -18.6 million USD | 96000 USD |
| 2018Q2 | -15.5 million USD | ? USD |
| 2018Q1 | -13.4 million USD | ? USD |
| 2017Q4 | -17.4 million USD | ? USD |
| 2017Q3 | -9.5 million USD | ? USD |
| 2017Q2 | 14.6 million USD | ? USD |
| 2017Q1 | -7.3 million USD | ? USD |
| 2016Q4 | -18.8 million USD | ? USD |
GRTS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -138.5 million USD | 1.3 million USD |
| 2022 | -113.1 million USD | 9.3 million USD |
| 2021 | -75.0 million USD | 46.7 million USD |
| 2020 | -104.6 million USD | 4.0 million USD |
| 2019 | -90.9 million USD | 4.4 million USD |
| 2018 | -64.8 million USD | 1.2 million USD |
| 2017 | -41.4 million USD | ? USD |
| 2016 | -18.8 million USD | ? USD |
GRTS
Price: $0.96
52 week price:
Earnings Per Share: -1.20 USD
P/E Ratio: -1.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 427892
Market Capitalization: 95.1 million